- Home
- PAR vs MYGN Comparison
PAR vs MYGN Comparison
Compare PAR & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- MYGN
- Stock Information
- Founded
- PAR 1968
- MYGN 1991
- Country
- PAR United States
- MYGN United States
- Employees
- PAR N/A
- MYGN N/A
- Industry
- PAR Office Equipment/Supplies/Services
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PAR Miscellaneous
- MYGN Health Care
- Exchange
- PAR Nasdaq
- MYGN Nasdaq
- Market Cap
- PAR 2.8B
- MYGN 2.0B
- IPO Year
- PAR N/A
- MYGN 1995
- Fundamental
- Price
- PAR $71.53
- MYGN $13.50
- Analyst Decision
- PAR Strong Buy
- MYGN Hold
- Analyst Count
- PAR 8
- MYGN 11
- Target Price
- PAR $79.25
- MYGN $24.27
- AVG Volume (30 Days)
- PAR 361.9K
- MYGN 1.1M
- Earning Date
- PAR 02-25-2025
- MYGN 02-25-2025
- Dividend Yield
- PAR N/A
- MYGN N/A
- EPS Growth
- PAR N/A
- MYGN N/A
- EPS
- PAR N/A
- MYGN N/A
- Revenue
- PAR $453,986,000.00
- MYGN $823,600,000.00
- Revenue This Year
- PAR N/A
- MYGN $13.82
- Revenue Next Year
- PAR $19.03
- MYGN $4.59
- P/E Ratio
- PAR N/A
- MYGN N/A
- Revenue Growth
- PAR 49.11
- MYGN 12.15
- 52 Week Low
- PAR $37.74
- MYGN $12.87
- 52 Week High
- PAR $82.24
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- PAR 40.00
- MYGN 32.61
- Support Level
- PAR $71.59
- MYGN $13.04
- Resistance Level
- PAR $75.47
- MYGN $13.77
- Average True Range (ATR)
- PAR 2.66
- MYGN 0.60
- MACD
- PAR -0.94
- MYGN 0.14
- Stochastic Oscillator
- PAR 4.41
- MYGN 24.51
About PAR PAR Technology Corporation
PAR Technology Corp together with its subsidiaries provides management technology solutions including software, hardware, and related services, integral to the point-of-sale infrastructure and task management, information gathering, assimilation, and communication services. It has two segments. The restaurant/ Retail segment provides point-of-sale and management technology solutions such as hardware, software, and integrated technical solutions to the restaurant and retail industries. The government segment provides intelligence, surveillance, and reconnaissance solutions and mission systems support. The company derives the majority of its revenues from the Restaurant/ Retail segment.
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.